Provided By GlobeNewswire
Last update: Sep 4, 2024
Patent Covers Combining LIXTE’s LB-100
with Various Innovative Cancer Immunotherapies
PASADENA, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT and LIXTW) (“LIXTE” or the “Company”) today announced it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent application number 16/467,721, titled, "Oxabicycloheptanes for Modulation of Immune Response,” for combining the Company’s LB-100 compound with various innovative cancer immunotherapies.
Read more at globenewswire.com2.83
+0.81 (+40.1%)
NASDAQ:LIXTW (7/3/2025, 1:01:10 PM)
0.22
0 (0%)
Find more stocks in the Stock Screener
Unusual volume stocks are being observed in Thursday's session.
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps.
Stay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
The trading volume of these stocks is deviating from the norm in today's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.